Veterinary Medicines

CITRAMOX L.A. 150 mg/ml suspension for injection for cattle and pigs

Authorised
  • Amoxicillin trihydrate
Download as PDF

Product identification

Medicine name:
CITRAMOX L.A. 150 mg/ml suspension for injection for cattle and pigs
CITRAMOX L.A. 150 MG/ML SUSPENSION INJECTABLE POUR BOVINS ET PORCINS
Active substance:
  • Amoxicillin trihydrate
Target species:
  • Cattle
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    172.20
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Milk
        3
        day
      • Meat and offal
        18
        day
    • Pig
      • Meat and offal
        20
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CA04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • Cardboard box with multi-layer polypropylene_ethylene vinyl alcohol_ polypropylene vial closed with bromobutyl rubber stopper and aluminium and plastic flip capsule, of capacity 250 ml
  • Cardboard box with multi-layer polypropylene_ethylene vinyl alcohol_ polypropylene vial closed with bromobutyl rubber stopper and aluminium and plastic flip capsule, of capacity 100 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Karizoo S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Przedsiebiorstwo Wielobranzowe Vet-Agro Sp. z o.o.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/7104511 9/2020
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0323/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Lithuania
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 14/11/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."